Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05244187 · ClinicalTrials.gov registry record · NA
Study to Evaluate the OrthoCor Active System for Pain Relief
A NA study of Pain, sponsored by Caerus Corporation.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 5
- Study locations
NCT05244187: Completed NA study of Pain, sponsored by Caerus Corporation.
NCT05244187 is a NA study of Pain that has completed, run by Caerus Corporation. The registered enrollment target is 120 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (61% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05244187, a NA study of Pain, has completed, sponsored by Caerus Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 5
- Study locations
Study Summary
This is a prospective, multi-center, randomized, pivotal study to evaluate the OrthoCor Active System in individuals prescribed its use in comparison with the standard of care intervention for pain relief.
Primary Outcome
Number of participants with adverse events
Conditions Studied
Interventions
- DEVICE OrthoCor Active System
Study Locations (5)
New York
- Orlin & Cohen Orthopedic Group - Smithtown
- Spinal Pain and Rehabilitation Medicine - Yonkers
Florida
- Andrews Research & Education Foundation - Gulf Breeze
Michigan
- GFC of Southeastern Michigan PC - Detroit
New Jersey
- Rothman Orthopedic Institute - Washington Township
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2022-11-07 |
| Est. Completion | 2023-11-23 |
| Phase | NA |
What the finished NCT05244187 record still lists
NCT05244187 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 304-participant average among 374 other Pain trials with a reported enrollment target (61% lower).
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 1 intervention - of which OrthoCor Active System is the first listed.
NCT05244187 lists 5 locations in 4 states (New York, Florida, Michigan).
Frequently Asked Questions
What is clinical trial NCT05244187 about?
NCT05244187 is a clinical study titled "Study to Evaluate the OrthoCor Active System for Pain Relief". This is a prospective, multi-center, randomized, pivotal study to evaluate the OrthoCor Active System in individuals prescribed its use in comparison with the standard of care intervention for pain relief.
What is the current status of trial NCT05244187?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2022-11-07. Estimated completion is 2023-11-23.
What conditions does trial NCT05244187 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT05244187?
The interventions under investigation include: OrthoCor Active System (DEVICE).
Who is sponsoring clinical trial NCT05244187?
This trial is sponsored by Caerus Corporation, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05244187 being conducted?
This trial has 5 study locations across Florida, Michigan, New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05244187's enrollment target sits among peer trials
120 135th of 374 higher than 229 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Pain With Dementia
RECRUITING · NA
-
Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI